Adenosine A 2a receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats

Clinical Science

Volumn 123, Issue 5, 2012, Pages 323-332

  Imarisio, Chiara ^a   Alchera, Elisa ^a   Sutti, Salvatore ^a   Valente, Guido ^a   Boccafoschi, Francesca ^a   Albano, Emanuele ^a   Carini, Rita ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Hepatocyte apoptosis; Liver injury; Non alcoholic fatty liver disease (NAFLD); Survival pathway

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ALANINE AMINOTRANSFERASE; CHOLINE; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STEARIC ACID; STRESS ACTIVATED PROTEIN KINASE 1; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; HEPATITIS; HISTOPATHOLOGY; LIPID STORAGE; LIPOTOXICITY; LIVER CELL; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; DRUG ADMINISTRATION SCHEDULE; FATTY LIVER; HEPATOCYTES; INJECTIONS, INTRAPERITONEAL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; PHENETHYLAMINES; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADENOSINE A2; STEARIC ACIDS;

EID: 84862579289     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110504     Document Type: Article

References (36)

1. Marchesini, G. and Marzocchi, R. (2007) Metabolic syndrome and NASH. Clin. Liver Dis. 11, 105-117.
2. Fabbrini, E., Sullivan, S. and Klein, S. (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679-689.
3. Reid, A. E. (2001) Nonalcoholic steatohepatitis. Gastroenterology 121, 711-723.
4. Sanyal, A. J. (2005) Mechanisms of disease: pathogenesis of non-alcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 46-53.
5. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. and Tiribelli, C. (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14, 72-81.
6. Brent, A. (2010) Neuschwander-tetri hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788.
7. Malhi, H. and Gores, G. J. (2008) Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 28, 360-369.
8. Cazanave, S. C. and Gores, G. J. (2010) Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin. Lipidol. 5, 71-85.
9. Czaja, M. J. (2010) JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol. Metab. 21, 707-13.
10. Haskó, G., Linden, J., Cronstein, B. and Pacher, P. (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discovery 7, 759-770.
11. Fredholm, B. B. (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell. Death Differ. 14, 1315-23.
12. Peralta, C., Hotter, G., Closa, D., Gelpí, E., Bulbena, O. and Roselló-Catafau, J. (1997) Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 25, 934-937.
13. Alchera, E., Dal Ponte, C., Imarisio, C., Albano, E. and Carini, R. (2010) Molecular mechanisms of liver preconditioning. World J. Gastroenterol. 16, 6058-6067.
14. Carini, R., De Cesaris, M. G., Splendore, R., Baldanzi, G., Nitti, M. P., Alchera, E., Filigheddu, N., Domenicotti, C., Pronzato, M. A., Graziani, A. and Albano, E. (2004) Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 127, 14-923.
15. Alchera, E., Tacchini, L., Imarisio, C., Dal Ponte, C., De Ponti, C., Gammella, E., Cairo, G., Albano, E. and Carini, R. (2008) Adenosine-dependent activation of hypoxiainducible factor-1 induces late preconditioning in liver cells. Hepatology 48, 230-239.
16. Wullsert, A., Heynick, K. and Beyaert, R. (2006) Mechanisms of crosstalk between TNF-induced NF-kB and JNK activation in hepatocytes. Biochem. Pharmacol. 72, 1090-1101.
17. Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, A. R. and Pasparakis, M. (2008) p37α MAPK inhibits JNK activation and collaborates with IkB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep. 9, 1048-1054.
18. Riccardi, C. and Nicoletti, I. (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1, 1458-1461.
19. Akiyoshi, H. and Terada, T. (1999) Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat. J. Hepatol. 30, 433-439.
20. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y. C., Torbenson, M. S., Unalp-Arida, A. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
21. Cantley, L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
22. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
23. Park, H. S., Kim, M. S., Huh, S. H., Park, J., Chung, J., Kang, S. S. and Choi, E. J. (2002) Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277, 2573-2578.
24. Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E. and Czaja, M. J. (2006) JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43, 163-172.
25. Singh, R.,Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde,W. A. and Czaja, M. J. (2009) Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49, 87-96.
26. Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Osterreicher, C. H., Schnabl, B., Seki, E. and Brenner, D. A. (2009) c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137, 1467-1477.
27. Kodama, Y., Taura, K., Miura, K., Schnabl, B., Osawa, Y. and Brenner, D. A. (2009) Antiapoptotic effect of c-Jun N-terminal kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 136, 1423-1434.
28. Sharma, M., Urano, F. and Jaeschke, A. (2012) Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes. J. Hepatol. 56, 192-198.
29. Cescon, M., Carini, R., Grazi, G., Caraceni, P., Alchera, E., Gasloli, G., Ravaioli, M., Tuci, F., Imarisio, C., Dal Ponte, C. et al. (2009) Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. J. Hepatol. 50, 937-947.
30. Larter, C. Z. and Yeh, M. M. (2008) Animal models of NASH: getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23, 1635-1648.
31. Peng, Z., Borea, P. A., Varani, K., Wilder, T., Yee, H., Chiriboga, L., Blackburn, M. R., Azzera, G., Resta, G. and Cronstein, B. N. (2009) Adenosine signaling contributes to ethanol-induced fatty liver in mice. J. Clin. Invest. 119, 582-594.
32. Witek, R. P., Stone, W. C., Karaca, F. G., Syn, W. K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S. et al. (2009) Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50, 1421-1430.
33. Joshi-Barve, S., Barve, S. S., Amancherla, K., Gobejishvili, L., Hill, D., Cave, M., Hote, P. and McClain, C. J. (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46, 823-830.
34. Peng, Z., Fernandez, P., Wilder, T., Yee, H., Chiriboga, L., Chan, E. S. and Cronstein, B. N. (2008) Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J. 22, 2263-2272.
35. 2a receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol. Pharmacol. 72, 1626-1636.
36. Serviddio, G., Bellanti, F., Giudetti, A. M., Gnoni, G. V., Petrella, A., Tamborra, R., Romano, A. D., Rollo, T., Vendemiale, G. and Altomare, E. (2010) A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. J. Pharmacol. Exp. Ther. 332, 922-932